Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00045916 · ClinicalTrials.gov registry record · Phase 4
Optimizing Electroconvulsive Therapy for Depression
A Phase 4 study of Depression and Bipolar Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 340
- Enrollment target
- 4
- Study locations
NCT00045916: Completed Phase 4 study of Depression and Bipolar Disorder, sponsored by New York State Psychiatric Institute.
NCT00045916 is a Phase 4 study of Depression and Bipolar Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 340 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00045916, a Phase 4 study of Depression and Bipolar Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 340 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will evaluate the effectiveness of electroconvulsive therapy (ECT) administered with medication for the treatment of a major depressive episode (unipolar or bipolar) and will compare two types of ECT.
Conditions Studied
Interventions
- DRUG Lithium
- DRUG Nortriptyline
- DRUG Venlafaxine
- PROCEDURE High dosage electroconvulsive therapy
- PROCEDURE Low dosage electroconvulsive therapy
Study Locations (4)
Missouri
- Washington University - St Louis
New York
- New York State Psychiatric Institute at Columbia University - New York
North Carolina
- Wake Forest University - Winston-Salem
Pennsylvania
- Western Psychiatric Institute and Clinic - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2001-02 |
| Est. Completion | 2006-12 |
| Phase | Phase 4 |
What the finished NCT00045916 record still lists
NCT00045916 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (57% lower).
The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 5 interventions - of which Lithium is the first listed.
NCT00045916 reports a single indexed study location in Missouri, New York, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00045916 about?
NCT00045916 is a clinical study titled "Optimizing Electroconvulsive Therapy for Depression". This study will evaluate the effectiveness of electroconvulsive therapy (ECT) administered with medication for the treatment of a major depressive episode (unipolar or bipolar) and will compare two types of ECT.
What is the current status of trial NCT00045916?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 340 participants. The study started on 2001-02. Estimated completion is 2006-12.
What conditions does trial NCT00045916 study?
This clinical trial studies the following conditions: Depression, Bipolar Disorder, Depressive Disorder.
What interventions are being tested in trial NCT00045916?
The interventions under investigation include: Lithium (DRUG), Nortriptyline (DRUG), Venlafaxine (DRUG), High dosage electroconvulsive therapy (PROCEDURE), Low dosage electroconvulsive therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00045916?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00045916 being conducted?
This trial has 4 study locations across Missouri, New York, North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00045916's enrollment target sits among peer trials
340 126th of 679 higher than 553 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
-
Dopaminergic Therapy for Anhedonia - 2
RECRUITING · Phase 4
-
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
RECRUITING · Phase 4
-
Buspirone and Melatonin for Depression Following Traumatic Brain Injury
RECRUITING · Phase 4
-
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
RECRUITING · Phase 4
-
Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia